DiaMedica Therapeutics Inc (DMAC)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.18
+0.01
(+0.32%)
After-Hours: 20:00
DiaMedica Therapeutics Cash from Investing (Quarterly): 4.208M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.208M |
| December 31, 2023 | 6.124M |
| September 30, 2023 | 1.196M |
| June 30, 2023 | -28.13M |
| March 31, 2023 | 2.509M |
| December 31, 2022 | 4.724M |
| September 30, 2022 | 2.072M |
| June 30, 2022 | 2.528M |
| March 31, 2022 | 2.214M |
| December 31, 2021 | -8.689M |
| September 30, 2021 | -12.83M |
| June 30, 2021 | 0.989M |
| March 31, 2021 | -0.009M |
| December 31, 2020 | 0.667M |
| September 30, 2020 | -14.00M |
| June 30, 2020 | 2.50M |
| March 31, 2020 | -5.301M |
| December 31, 2019 | 1.008M |
| September 30, 2019 | 3.00M |
| June 30, 2019 | 3.012M |
| March 31, 2019 | -10.93M |
| December 31, 2018 | 0.013M |
| September 30, 2018 | -0.021M |
| June 30, 2018 | -0.01M |
| March 31, 2018 | -0.032M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0153M |
| September 30, 2017 | -0.0039M |
| June 30, 2017 | -0.0028M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0041M |
| September 30, 2016 | -0.0007M |
| June 30, 2016 | -0.0049M |
| March 31, 2016 | 0.0027M |
| December 31, 2015 | -0.0003M |
| September 30, 2015 | -0.0011M |
| June 30, 2015 | 0.0002M |
| March 31, 2015 | -0.0021M |
| December 31, 2014 | 0.0013M |
| September 30, 2014 | -0.0151M |
| June 30, 2014 | -0.0006M |
| March 31, 2014 | -0.0169M |
| December 31, 2013 | -0.0242M |
| September 30, 2013 | -0.037M |
| June 30, 2013 | -0.0314M |
| March 31, 2013 | -0.0416M |
| December 31, 2012 | -0.0168M |
| September 30, 2012 | -0.0112M |
| June 30, 2012 | -0.0298M |
| March 31, 2012 | -0.0056M |
| December 31, 2011 | -0.0474M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-28.13M
Minimum
Jun 2023
6.124M
Maximum
Dec 2023
-1.610M
Average
1.634M
Median
Cash from Investing (Quarterly) Benchmarks
| NextCure Inc | 17.88M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.653M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -20.32M |
| Free Cash Flow Per Share (Quarterly) | -0.1755 |
| Free Cash Flow Yield | -18.15% |